- Home
- NBIX vs LAMR Comparison
NBIX vs LAMR Comparison
Compare NBIX & LAMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBIX | LAMR |
|---|---|---|
| Founded | 1992 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 13.1B |
| IPO Year | 1996 | 1996 |
Fundamental Metrics
Financial Performance| Metric | NBIX | LAMR |
|---|---|---|
| Price | $155.43 | $132.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 4 |
| Target Price | ★ $173.79 | $131.75 |
| AVG Volume (30 Days) | ★ 969.9K | 496.4K |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 4.67% |
| EPS Growth | ★ 12.44 | N/A |
| EPS | 4.19 | ★ 4.24 |
| Revenue | ★ $2,682,700,000.00 | $2,253,062,000.00 |
| Revenue This Year | $23.76 | $4.38 |
| Revenue Next Year | $18.01 | $4.46 |
| P/E Ratio | $37.10 | ★ $31.32 |
| Revenue Growth | ★ 19.61 | 2.98 |
| 52 Week Low | $84.23 | $99.84 |
| 52 Week High | $157.67 | $134.63 |
Technical Indicators
Market Signals| Indicator | NBIX | LAMR |
|---|---|---|
| Relative Strength Index (RSI) | 64.81 | 65.90 |
| Support Level | $150.26 | $130.56 |
| Resistance Level | $154.35 | $133.26 |
| Average True Range (ATR) | 4.16 | 2.45 |
| MACD | 1.07 | 0.07 |
| Stochastic Oscillator | 93.25 | 79.83 |
Price Performance
Historical ComparisonAbout NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About LAMR Lamar Advertising Company
Lamar Advertising Co is an outdoor advertising companies in the United States and operates as a Real Estate Investment Trust. It rent space for advertising on billboards, buses, shelters, benches, logo plates and in airport terminals and also offer customers a fully integrated service with all aspects of their display requirements from ad copy production to placement and maintenance. It has two operating segments: billboard and Others. Key revenue is generated from Billboard segment.